Biosense Submission Processes Assessment

Surveys of State, Tribal, Local and Territorial (STLT) Governmental Health Agencies

Attachment K_Instrument_Cost_12 19 13

Biosense Submission Processes Assessment

OMB: 0920-0879

Document [docx]
Download: docx | pdf

ATTACHMENT – K: Data Collection Instrument Form approved

OMB No. 0920-0879

Expiration date: 03/31/2014


Information Collection Instrument: Cost Assessment (Part 2)

To create a Part 1 only information collection, do not present the STLT agency with this instrument.

To create a Part 1 and 2 information collection, remove all questions highlighted in yellow to minimize respondent burden and avoid duplication of questions.

To create a Part 2 only information collection, present the STLT agency will this entire instrument.


  • Thank you for agreeing to speak with us today. My name is [NAME OF INTERVIEWER] and I am a [POSITION] at RTI International. We have been contracted by the CDC to assess BioSense onboarding activities and associated costs. The purpose of today’s interview is to gain a better understanding of your jurisdiction’s onboarding experiences and the challenges, and opportunities you have encountered as a result of joining BioSense. We are especially interested in learning about the factors that influenced your decision to join BioSense, your current and future plans for the BioSense data, and suggestions for improving the system. We will be using the information and feedback you share with us today to improve the onboarding processes and will communicate these lessons learned to the BioSense community and CDC through an issue brief that will be posted to the collaboration site.

  • In order to make sure we all understand some of the terms we will be using I want to go over a few definitions:

    • When we use the term syndromic surveillance this means the ongoing, systematic collection, analysis, interpretation, and application of real-time (or near-real-time) indicators for diseases and outbreaks that allow for early detection, situation awareness and response. Syndromic surveillance emphasizes timeliness and applies automated analysis and visualization tools to screen non-specific indicator data in electronic form so as to detect unexpected patterns that warrant investigation.

    • The term Onboarding Team refers to any of the individuals you worked with from RTI.

    • The term Onboarding Coordinator refers to your main point of contact at RTI.

[ REMIND THEM THAT IT WAS ONE OF THE FOLLOWING: JESSE, SUJATHA, RITA, SHELLERY ]

  • With your permission, we will be recording our interview to help ensure our notes are accurate. All information given during the interview including notes and recordings will be kept secure. Direct quotes will not identify names or sites. Do you agree to allow us to record this interview? [WAIT FOR A VERBAL RESPONSE. IF NO, DO NOT RECORD]




About Your Organization


  1. What is your title? [COST ONLY]____________________________________________________


  1. What is your role in your department and what are your main responsibilities? [COST ONLY]___ ______________________________________________________________________________

______________________________________________________________________________


  1. To help us better understand your responsibilities, please characterize the organizational structure in which your jurisdiction’s syndromic surveillance activities/operations reside. [COST ONLY]

    1. In what agency and division do your syndromic surveillance activities reside (e.g., Department of Health, Office of the State Epidemiologist)? _______________________­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­

_______________________________________________________________________


    1. What other job functions do those engaged in and/or managing syndromic surveillance have? __________________________________________________________________

________________________________________________________________________


    1. Have you collaborated with other state offices or divisions on any aspect of BioSense? Please describe this collaboration. _______________________________________­_

________________________________________________________________________


  1. How many counties or municipalities are under your jurisdiction? ____________________


  1. What is the size of the population served by your department? _____________ people


  1. How many health information technology facilities are in your jurisdiction? __________


  1. Does your jurisdiction have a Health Information Exchange currently?

  • Yes

  • No


    1. [If YES] Please describe. ____________________________________________________

________________________________________________________________________


    1. [If NO] Please describe any future HIE plans. ___________________________________

________________________________________________________________________



Syndromic Surveillance Questions


  1. Approximately, when did your jurisdiction begin to engage in in syndromic surveillance (i.e., in what year)? __________


    1. Please describe your jurisdiction’s experience and history with syndromic surveillance.

________________________________________________________________________

________________________________________________________________________

  1. Do you currently use BioSense 2.0? (Please check all that apply) [COST ONLY]

  • Yes, we are submitting data

  • Yes, we are using BioSense tools to analyze our data

  • Yes, we are using BioSense tools to analyze other jurisdictions data compared to ours

  • No, we are not using BioSense 2.0 at all


    1. [If YES to any statements] Please describe your adoption and your use of BioSense 2.0 to date and your reasons for doing so.___________________________________________ ________________________________________________________________________

________________________________________________________________________

________________________________________________________________________


    1. [If NO statement selected] Please describe your planned future use of BioSense 2.0. Please also describe any rationale for not having any planned use of BioSense 2.0. _____ ________________________________________________________________________

________________________________________________________________________

________________________________________________________________________


[If Q9 response includes “Yes, we are submitting data”, ask the following questions]


  1. How many data streams does your jurisdiction send to BioSense 2.0 currently?

__________ streams


    1. [If ZERO] How many steams does your jurisdiction plan to send in the future?

__________ streams


  1. How do you currently transmit data? [COST ONLY]

  • SFTP

  • PHINMS

  • HTTPS

  • Mirth to Mirth

  • Other (______________________________________________)


  1. Are you transmitting messages using an HL7 message format? [COST ONLY]

  • Yes

  • No


    1. [If YES] Is there an extra level of burden /cost associated with using HL7? Where their adoption costs involved? ___________________________________________________

________________________________________________________________________

________________________________________________________________________


  1. Is the data consolidated by your jurisdiction prior to transmission to BioSense 2.0?

  • YES

  • NO


    1. How many streams do you consolidate prior to transmission to BioSense? __________


    1. Do you receive any consolidated streams prior to transmission to BioSense? If so, approximately how many? __________________________________________________


    1. Consider the consolidate streams that you receive. Approximately how many individual streams were consolidated? ___________________________________________



Syndromic Surveillance – Budget and Resources


  1. Does your jurisdiction have an official budget or budget line item for syndromic surveillance, or is it part of a broader budget or multiple units’ budgets?

  • We have an official budget or budget line item for syndromic surveillance

  • In my jurisdiction, syndromic surveillance is part of a broader budget or multiple units’ budgets


    1. If there is a specific budget just for syndromic surveillance, what is it?

$ __________________


      1. Can you share this with us?

  • Yes

  • No


    1. If there is not a budget per se, but you may be able to estimate the amount you currently spend on syndromic surveillance, what would you estimate?

$ ___________________


      1. What costs are included in your estimates? Please select all that apply.

        • Salaries

        • Software agreements

        • Other (________________________________________________________

_____________________________________________________________)


    1. If known, approximately what proportion of your actual or estimated annual budget / spending on syndromic surveillance is supported by the following:

  • State sources_________

  • Municipal or county sources ___________

  • Federal sources (e.g., CDC) _________

  • Other sources (_______________________________________________________)








  1. Using the following table, please tell us about the staffing that currently support syndromic surveillance in some way, from executive management through technical support.

Position title

# of staff

Equivalent FTEs working on SS*

FTEs within your admin unit

FTEs working on / with BioSense

Comments?
































*Sum of all part and full staff time spent working on syndromic surveillance each year.


  1. What software packages do you use to support your syndromic surveillance activities?


Software Package / Analytics Service

Approx. Purchase Date

Approx. Purchase Amount

Approx. Annual License Fee

Approx. Number of Users

Does this tool support more than your SS activities?

Comments































BioSense 2.0 Specific – Labor and Capital Questions


  1. Please estimate the amount labor spent in each of the following areas.


Activity

Which staff / positions (from Q15) are / were engaged in this activity?

For how long were they / are they engaged in this activity?

What % of their time (approximately) were they / are they Engaged in this activity?

Developing Data Use Agreements




Labor spent developing DUAs




Technical Implementation




Learning about BioSense 2.0




Integrating use of BioSense 2.0- into our organizational policies & procedures




Developing/converting software to connect with BioSense 2.0




Testing BioSense 2.0




Labor spent on testing




Maintenance (Post-Implementation. & Testing)




Fixing problems that arise




Updating software / hardware




Use of BioSense




Submitting data / managing uploads (if any)




Using BioSense 2.0 tools to analyze our data




Using BioSense 2.0 tools to analyze other jurisdictions data compared to ours





  1. Have you spent time helping additional facilities with BioSense 2.0 onboarding?

  • Yes

  • No


    1. [If YES] When adding new health information technology facilities do you ask them to submit their data into the BioSense 2.0 state / city locker or submit their data through your HIE (if there is one)?

    • We ask them to submit their data into the BioSense 2.0 state locker

    • We ask them to submit their data through your HIE

    • Other (______________________________________________________________)


    1. [If YES] How much time have you spent working with new health information technology facilities to help them with onboarding?


________ hours over the last _________ years


    1. [If YES] Have you expended any other resources in order to help others facilities with onboarding?


$__________ over the last _________ years


  1. Has staffing been stable, decreasing, or increasing over the course of your engagement in BioSense 2.0?

  • Been stable

  • Decreasing

  • Increasing


Please describe your response. _________________________________________________

___________________________________________________________________________


  1. Please describe your planned future usage of BioSense 2.0.______________________________

______________________________________________________________________________

______________________________________________________________________________


  1. If you do not plan to use BioSense 2.0 or if were not available, what would you do to comply with Meaningful Use? What related expenses would you incur? __________________________

______________________________________________________________________________

______________________________________________________________________________

______________________________________________________________________________

______________________________________________________________________________

______________________________________________________________________________



Additional Questions on BioSense 2.0 Experience


  1. Describe you/your staff’s routine, day to day use of BioSense 2.0. [COST ONLY]

      • For what purposes? __________________________________________________________

      • What features are you accessing? _______________________________________________

      • When and how frequently? ____________________________________________________

      • Who is accessing the system? ___________________________________________________


  1. Have you used BioSense 2.0 to monitor a public health threat (e.g., weather event, outbreak, a public gathering)? [COST ONLY]

  • Yes

  • No


    1. [If YES] Describe how you used BioSense 2.0.

      1. For what purposes? __________________________________________________

      2. What features did you access? __________________________________________

      3. When and how frequently throughout the event/period? ____________________

___________________________________________________________________

      1. Who was accessing the system? ________________________________________


  1. In addition to the uses you have described, is there any interest either from within or outside the health department for using BioSense 2.0 for other purposes? [COST ONLY]

  • Yes

  • No


    1. [If YES] Describe the nature of the interest in using BioSense 2.0 for other purpose.

    1. For what purposes?

    2. For what features?


  1. What specific challenges have you encountered/or expect to encounter in using BioSense 2.0 for surveillance? [COST ONLY]_________________________________________________________

______________________________________________________________________________

______________________________________________________________________________


  1. If you could change one thing about BioSense 2.0 to make it more useful for your jurisdiction, what would you change? [COST ONLY] _______________________________________________

______________________________________________________________________________



Characteristics of Interest

Answer

Description

Notes

Do they have a HIE? (YES or NO)

 

 

 

How much experience do they have syndromic surveillance? (# of years)

 

 

 

How many counties or municipalities are in the jurisdiction?

 

 

 

What is the size of the population served by the jurisdiction?

 

 

 

How many health information technology facilities does the jurisdiction include?

 

 

 

How many data streams does the jurisdiction send to BioSense? (# of streams)

 

 

 

How do they transmit data? (SFTP, PHINMS, HTTP, Mirth to Mirth, other??)

 

 

 

Is the data consolidated by jurisdiction prior to transmission to BioSense 2.0?

 

 

 

If YES to previous question, how much data is aggregated? (# of org's)

 

 

 

Are they transmitting in HL7 format?

 

 

 


Public reporting burden of this collection of information is estimated to average 1.5 hours per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to a collection of information unless it displays a currently valid OMB control number.  Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to CDC/ATSDR Information Collection Review Office, 1600 Clifton Road NE, MS D-74,  Atlanta, Georgia 30333; ATTN:  PRA (0920-0879).

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
AuthorRowe, Brent
File Modified0000-00-00
File Created2021-01-31

© 2024 OMB.report | Privacy Policy